XML 22 R8.htm IDEA: XBRL DOCUMENT v2.3.0.15
RESTATEMENT
6 Months Ended
Jun. 30, 2011
RESTATEMENT 
RESTATEMENT
2.  RESTATEMENT
 
In the third quarter of 2008, the Company began manufacturing the first generation (Gen 1) of its super giant tires.  In the fourth quarter of 2009, the Company ceased manufacturing Gen 1 tires due to the creation of the second generation (Gen 2) of super giant tires which began production in the first quarter of 2010.  During the fourth quarter of 2010, the Company recorded a $5.1 million charge to reduce the remaining Gen 1 tire inventory to an estimated market value of $10.6 million.  In October of 2011, the Company determined that the analysis performed in the fourth quarter of 2010 that created the $5.1 million adjustment was not reflective of all the facts and circumstances that existed at December 31, 2010.  After reconsidering the facts and circumstances that existed at December 31, 2010, the Company determined that the estimated market value of the Gen 1 tires that remained as of December 31, 2010 was $0.7 million.  Accordingly, the Company is restating its consolidated financial statements as of and for the year ended December 31, 2010 to reflect an additional charge of $9.8 million for its Gen 1 inventory.  In addition, this Form 10-Q/A reflects the reversal of a related inventory decrease of $0.4 million which was previously recorded in the quarter ended June 30, 2011.
 
The following table represents the impact of the restatement adjustments on the Company’s Consolidated Condensed Statement of Operations for the three and six months ended June 30, 2011 (amounts in thousands, except share and per share data):
   
CONSOLIDATED CONDENSED STATEMENTS OF OPERATION (UNAUDITED)
 
   
Three months ended June 30, 2011
  
Six months ended June 30, 2011
 
   
Previously Reported
  
Restatement Adjustment
  
Restated
  
Previously Reported
  
Restatement Adjustment
  
Restated
 
Net sales
 $404,447  $0  $404,447  $685,276  $0  $685,276 
Cost of sales
  340,556   (443)  340,113   565,113   (443)  564,670 
Gross profit
  63,891   443   64,334   120,163   443   120,606 
Selling, general and administrative expenses
  16,573   0   16,573   41,866   0   41,866 
Research and development expenses
  1,014   0   1,014   2,197   0   2,197 
Royalty expense
  2,350   0   2,350   5,267   0   5,267 
Income from operations
  43,954   443   44,397   70,833   443   71,276 
Interest expense
  (6,149)  0   (6,149)  (12,429)  0   (12,429)
Noncash convertible debt conversion charge
  0   0   0   (16,135)  0   (16,135)
Other income
  2,270   0   2,270   2,463   0   2,463 
Income before income taxes
  40,075   443   40,518   44,732   443   45,175 
Income tax provision
  14,798   164   14,962   22,491   164   22,655 
Net income
  25,277   279   25,556   22,241   279   22,520 
Net (loss) attributable to noncontrolling interests
  (8)  0   (8)  (8)  0   (8)
Net income attributable to Titan
 $25,285  $279  $25,564  $22,249  $279  $22,528 
Earnings per common share:
                        
  Basic
 $.60  $.01  $.61  $.54  $.01  $.55 
  Diluted
  .49   .01   .50   .46   .01   .47 
Average common shares and equivalents outstanding:
                        
  Basic
  41,981   41,981   41,981   41,250   41,250   41,250 
  Diluted
  53,394   53,394   53,394   53,229   53,229   53,229 
                          
  Dividends declared per common share
 $.005      $.005  $.010      $.010 


 
 
The following table represents the impact of the restatement adjustments on the Company’s Consolidated Condensed Balance Sheets (Unaudited) as of June 30, 2011 and December 31, 2010 (amounts in thousands):

   
CONSOLIDATED CONDENSED BALANCE SHEETS (UNAUDITED)
 
   
June 30, 2011
  
December 31, 2010
 
Assets
 
Previously Reported
  
Restatement Adjustment
  
Restated
  
Previously Reported
  
Restatement Adjustment
  
Restated
 
Current assets
                  
  Cash and cash equivalents
 $114,162  $0  $114,162  $239,500  $0  $239,500 
  Accounts receivable
  243,478   0   243,478   89,004   0   89,004 
  Inventories
  183,763   (9,396)  174,367   127,982   (9,839)  118,143 
  Deferred income taxes
  13,102   3,085   16,187   12,791   3,249   16,040 
  Prepaid and other current assets
  29,671   0   29,671   18,663   0   18,663 
    Total current assets
  584,176   (6,311)  577,865   487,940   (6,590)  481,350 
                          
  Property, plant and equipment, net
  353,546   0   353,546   248,054   0   248,054 
  Other assets
  133,970   0   133,970   51,476   0   51,476 
                          
Total assets
 $1,071,692  $(6,311) $1,065,381  $787,470  $(6,590) $780,880 
                          
Liabilities and Stockholders’ Equity
                        
Current liabilities
                        
  Short-term debt
 $10,330  $0  $10,330  $0  $0  $0 
  Accounts payable
  114,837   0   114,837   35,281   0   35,281 
  Other current liabilities
  102,352   0   102,352   57,072   0   57,072 
    Total current liabilities
  227,519   0   227,519   92,353   0   92,353 
                          
  Long-term debt
  317,881   0   317,881   373,564   0   373,564 
  Deferred income taxes
  48,227   (306)  47,921   1,970   (306)  1,664 
  Other long-term liabilities
  79,364   0   79,364   41,268   0   41,268 
Total liabilities
  672,991   (306)  672,685   509,155   (306)  508,849 
                          
Stockholders’ equity
                        
  Common stock
  37   0   37   30   0   30 
  Additional paid-in capital
  377,565   0   377,565   300,540   0   300,540 
  Retained earnings
  37,856   (6,005)  31,851   16,028   (6,284)  9,744 
  Treasury stock
  (18,172)  0   (18,172)  (19,324)  0   (19,324)
  Treasury stock reserved for    contractual obligations
  (1,233)  0   (1,233)  (1,917)  0   (1,917)
  Accumulated other comprehensive income (loss)
  727   0   727   (17,042)  0   (17,042)
    Total Titan stockholders equity
  396,780   (6,005)  390,775   278,315   (6,284)  272,031 
  Noncontrolling interests
  1,921   0   1,921   0   0   0 
Total stockholders’ equity
  398,701   (6,005)  392,696   278,315   (6,284)  272,031 
                          
Total liabilities and stockholders’ equity
 $1,071,692  $(6,311) $1,065,381  $787,470  $(6,590) $780,880 


 
 

The following table represents the impact of the restatement adjustments on the Company’s cash flows from operating activities for the six months ended June 30, 2011 (amounts in thousands):
   
                                                                Six Months Ended June 30, 2011
 
   
Previously Reported
  
Restatement Adjustment
  
Restated
 
Cash flows from operating activities:
         
Net income
 $22,241  $279  $22,520 
Adjustments to reconcile net income to net cash
            
provided by operating activities:
            
Depreciation and amortization
  21,146   0   21,146 
Deferred income tax provision
  8,282   164   8,446 
Noncash convertible debt conversion charge
  16,135   0   16,135 
Stock-based compensation
  1,384   0   1,384 
Issuance of treasury stock under 401(k) plan
  268   0   268 
Gain on acquisition
  (919)  0   (919)
(Increase) decrease in assets:
            
Accounts receivable
  (152,495)  0   (152,495)
Inventories
  (34,525)  (443)  (34,968)
Prepaid and other current assets
  (6,088)  0   (6,088)
Other assets
  (222)  0   (222)
Increase (decrease) in liabilities:
            
Accounts payable
  77,736   0   77,736 
Other current liabilities
  19,269   0   19,269 
Other liabilities
  (2,844)  0   (2,844)
Net cash used for operating activities
 $(30,632) $0  $(30,632)

The restatement adjustments did not impact the total net cash flows from financing and investing activities in the Consolidated Statement of Cash Flows for the year ended December 31, 2010.  Additionally, all amounts in notes to the Consolidated Condensed Financial Statements (Unaudited) affected by the restatements have been labeled as restated